Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987961 · ClinicalTrials.gov registry record · Phase 3
Linking Hospitalized Injection Drug Users to Buprenorphine
A Phase 3 study of Opiate Dependence, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 147
- Enrollment target
- 1
- Study location
NCT00987961 is a Phase 3 study of Opiate Dependence that has completed, run by Butler Hospital. The registered enrollment target is 147 participants, below the 598-participant average among 15 other Opiate Dependence trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00987961, a Phase 3 study of Opiate Dependence, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 147 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests whether starting Suboxone (buprenorphine) during a medical hospitalization, and then providing an appointment (a "link") for after discharge to maintenance buprenorphine in an outpatient setting will reduce HIV risk behavior in individuals who inject opioids.
Conditions Studied
Interventions
- BEHAVIORAL Linkage
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00987961
The ClinicalTrials.gov registry entry for NCT00987961 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 598-participant average among 15 other Opiate Dependence trials with a reported enrollment target (75% lower). The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opiate Dependence appearing as the primary indexed condition, and to 1 intervention - of which Linkage is the first listed.
NCT00987961 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00987961 about?
NCT00987961 is a clinical study titled "Linking Hospitalized Injection Drug Users to Buprenorphine". This study tests whether starting Suboxone (buprenorphine) during a medical hospitalization, and then providing an appointment (a "link") for after discharge to maintenance buprenorphine in an outpatient setting will reduce HIV risk behavior in individuals who inject opioids.
What is the current status of trial NCT00987961?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 147 participants. The study started on 2009-09. Estimated completion is 2015-09.
What conditions does trial NCT00987961 study?
This clinical trial studies the following conditions: Opiate Dependence.
What interventions are being tested in trial NCT00987961?
The interventions under investigation include: Linkage (BEHAVIORAL).
Who is sponsoring clinical trial NCT00987961?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00987961 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiate Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
COMPLETED · Phase 3
-
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
COMPLETED · Phase 3
-
Substance Abuse Pre-Treatment Screening Study
RECRUITING
-
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
RECRUITING · Phase 2
-
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
COMPLETED · NA
-
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.